This Article Full Text (OnlineFirst PDF) All Versions of this Article: 1753944708094736v1 2/6/485    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Ang, L. Articles by Mahmud, E. Search for Related Content PubMed PubMed Citation Articles by Ang, L. Articles by Mahmud, E. Social Bookmarking                         What's this?

Monitoring oral antiplatelet therapy: is it justified?

¹ Division of Cardiovascular Medicine, University of California, San Diego, San Diego, CA, USA
² Cardiovascular Catheterization Laboratory, UCSD Medical Center, 200 West Arbor Drive, San Diego, CA 92103-8784, USA

^* To whom correspondence should be addressed.

	Abstract

Platelets play a key role in the initial formation and progression of intravascular thrombus. During coronary and peripheral vascular interventions, antiplatelet therapy is used to impair platelet reactivity in order to minimize adverse ischemic events. Chronic antiplatelet therapy is also administered to decrease the long term risk of major adverse cardiovascular events in patients with high atherothrombotic burden. However, due to a heterogeneous response to antiplatelet agents, a substantial number of patients with cardiovascular disease remain at risk despite adherence to therapy. Since the availability of point-of-care rapid platelet function assays, quick and reproducible evaluation of platelet function after the administration of aspirin, thienopyridines, and glycoprotein IIb/IIIa inhibitors is possible. Various definitions of suboptimal platelet inhibition with oral antiplatelet therapy and associated risk factors are presented here. An algorithm to guide optimal antiplatelet therapy based on rapid platelet function testing during cardiovascular interventions is also presented.

Key Words: platelets, antiplatelet medications, platelet function assay

First published on August 21, 2008, doi:10.1177/1753944708094736

Therapeutic Advances in Cardiovascular Disease 2008;2:485.

A more recent version of this article appeared on December 1, 2008


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?